Oncology Institute Inc (TOI) — Capital Reinvestment Ratio
Latest as of December 2025:
0.33x
Oncology Institute Inc (TOI) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow ($3.23 Million) in capital expenditures ($1.06 Million). See Oncology Institute Inc (TOI) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.33x
Capex / Operating Cash Flow
Operating Cash Flow
$3.23 Million
USD
Capital Expenditures
$1.06 Million
USD
Data as of
Dec 2025
Most recent filing
Oncology Institute Inc Capital Reinvestment Ratio (2018–2020)
This chart tracks Oncology Institute Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Oncology Institute Inc (2018–2020)
Year-by-year Capital Reinvestment Ratio for Oncology Institute Inc from 2018 to 2020. For live market cap and broader valuation context, see market cap of Oncology Institute Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.35x | $508.00K | $1.19 Million | ▲ +605.4% |
| 2019 | 0.33x | $3.62 Million | $1.20 Million | ▲ +170.1% |
| 2018 | 0.12x | $5.64 Million | $695.96K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow